Agios Pharmaceuticals (8AP.MU) Q1 2026 Earnings

12FebConfirmed
Q1 2026
-1.65
-1.62
-1.59
-1.57

Details

Expected EPS
-1.64607713832
Actual EPS
-1.5671244
Surprise EPS
0.08
Surprise Percent
+4.8%

Description

Agios Pharmaceuticals (8AP.MU) has reported earnings of -1.5671244 per share for Q1 2026.

0 Comments

Share your thoughts